Novo Nordisk inks $812M Deep Apple deal to pursue obesity target – Fierce Biotech
The Danish drugmaker has partnered with Deep Apple Therapeutics to access small molecules against a non-incretin GPCR target.Read More
The Heartbeat of World events
The Danish drugmaker has partnered with Deep Apple Therapeutics to access small molecules against a non-incretin GPCR target.Read More